These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 38905450)
1. Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation. Anderson CJ; Yang H; Parsons J; Ahrens WA; Jagosky MH; Hsu JH; Patt JC; Kneisl JS; Steuerwald NM Clin Orthop Relat Res; 2024 Jun; ():. PubMed ID: 38905450 [TBL] [Abstract][Full Text] [Related]
2. Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors. Christodoulou E; Yellapantula V; O'Halloran K; Xu L; Berry JL; Cotter JA; Zdanowicz A; Mascarenhas L; Amatruda JF; Ostrow D; Bootwalla M; Gai X; Navid F; Biegel JA NPJ Precis Oncol; 2023 Feb; 7(1):21. PubMed ID: 36805676 [TBL] [Abstract][Full Text] [Related]
3. Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease. Hemming ML; Klega KS; Rhoades J; Ha G; Acker KE; Andersen JL; Thai E; Nag A; Thorner AR; Raut CP; George S; Crompton BD JCO Precis Oncol; 2019; 2019():. PubMed ID: 30793095 [TBL] [Abstract][Full Text] [Related]
4. Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations. Bouzidi A; Labreche K; Baron M; Veyri M; Denis JA; Touat M; Sanson M; Davi F; Guillerm E; Jouannet S; Charlotte F; Bielle F; Choquet S; Boëlle PY; Cadranel J; Leblond V; Autran B; Lacorte JM; Spano JP; Coulet F; Front Cell Dev Biol; 2021; 9():661272. PubMed ID: 34710202 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment. Sogbe M; Bilbao I; Marchese FP; Zazpe J; De Vito A; Pozuelo M; D'Avola D; Iñarrairaegui M; Berasain C; Arechederra M; Argemi J; Sangro B Clin Mol Hepatol; 2024 Apr; 30(2):177-190. PubMed ID: 38163441 [TBL] [Abstract][Full Text] [Related]
6. Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients. Frydendahl A; Nors J; Rasmussen MH; Henriksen TV; Nesic M; Reinert T; Afterman D; Lauterman T; Kuzman M; Gonzalez S; Glavas D; Smadback J; Maloney D; Levativ J; Yahalom M; Ptashkin R; Tavassoly I; Donenhirsh Z; White E; Kandasamy R; Alon U; Nordentoft I; Lindskrog SV; Dyrskjøt L; Jaensch C; Løve US; Andersen PV; Thorlacius-Ussing O; Iversen LH; Gotschalck KA; Zviran A; Oklander B; Andersen CL Eur J Cancer; 2024 Nov; 211():114314. PubMed ID: 39316995 [TBL] [Abstract][Full Text] [Related]
7. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study. Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE Front Oncol; 2023; 13():1176698. PubMed ID: 37333831 [TBL] [Abstract][Full Text] [Related]
8. Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma. Sato T; Montazeri K; Gragoudas ES; Lane AM; Aronow MB; Cohen JV; Boland GM; Banks E; Kachulis C; Fleharty M; Cibulskis C; Lawless A; Adalsteinsson VA; Sullivan RJ; Kim IK JCO Precis Oncol; 2024 Jan; 8():e2300368. PubMed ID: 38237100 [TBL] [Abstract][Full Text] [Related]
9. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples. Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856 [TBL] [Abstract][Full Text] [Related]
11. Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer. Kim MH; Kim GM; Ahn JM; Ryu WJ; Kim SG; Kim JH; Kim TY; Han HJ; Kim JY; Park HS; Park S; Park BW; Kim SI; Jeong J; Lee J; Paik S; Kim S; Jung KH; Cho EH; Sohn J J Natl Cancer Inst; 2023 Sep; 115(9):1036-1049. PubMed ID: 37166557 [TBL] [Abstract][Full Text] [Related]
12. Using circulating cell-free DNA to monitor personalized cancer therapy. Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575 [TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy: current technology and clinical applications. Nikanjam M; Kato S; Kurzrock R J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847 [TBL] [Abstract][Full Text] [Related]
14. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing. Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131 [TBL] [Abstract][Full Text] [Related]
15. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients. Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434 [TBL] [Abstract][Full Text] [Related]
16. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995 [TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection. Wei Q; Jin C; Wang Y; Guo S; Guo X; Liu X; An J; Xing J; Li B Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649341 [TBL] [Abstract][Full Text] [Related]
19. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program. Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761 [TBL] [Abstract][Full Text] [Related]
20. Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors. Zhao J; Reuther J; Scozzaro K; Hawley M; Metzger E; Emery M; Chen I; Barbosa M; Johnson L; O'Connor A; Washburn M; Hartje L; Reckase E; Johnson V; Zhang Y; Westheimer E; O'Callaghan W; Malani N; Chesh A; Moreau M; Daber R Mol Diagn Ther; 2023 Nov; 27(6):753-768. PubMed ID: 37632661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]